Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Share-Based Compensation Expense

The table below sets forth the line items where share-based compensation expense was recorded for the twelve months ended December 31:

	2022		2021		2020
Cost of goods sold	$	1,630	$	1,321	$	1,064
Selling, general and administrative expense		30,295		28,188		21,013
Research and development expense		4,362		3,696		3,183
Total share-based compensation expense	$	36,287	$	33,205	$	25,260

Schedule of Share-Based Compensation Expense by Type

The table below sets forth share-based compensation expense by type for the twelve months ended December 31:

	2022		2021		2020
Stock options	$	36	$	73	$	-
Share grants		36,251		33,132		25,260
Total share-based compensation expense	$	36,287	$	33,205	$	25,260

Summary of Nonvested Share Grants

The table below sets forth a summary of our non-vested share grants in 2022, 2021 and 2020:

Restricted Stock Grants	Shares			Weighted Average Grant Date Fair Value ($)		Aggregate Intrinsic Value
Nonvested at December 31, 2019		1,697			31.71
Granted		573			48.83
Vested		(770	)		27.78
Forfeited and other		88			38.31
Nonvested at December 31, 2020		1,588			39.30
Granted		598			79.26
Vested		(750	)		33.39
Forfeited and other		(34	)		52.27
Nonvested at December 31, 2021		1,402			54.94
Granted		535			69.87
Vested		(614	)		45.96	$	46,633
Forfeited and other		(55	)		61.87
Nonvested at December 31, 2022		1,269			65.29	$	96,634

Schedule of Share Based Compensation Stock Options Activity

The table below sets forth a summary of activity in our stock option plan:

Stock Options	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding and exercisable at December 31, 2020		192			23.32			$	9,059
Exercised		(187	)		23.19			$	10,631
Outstanding and exercisable at December 31, 2021		5			27.92		0.4	$	409
Exercised		(5	)		27.92		0.4	$	409
Outstanding and exercisable at December 31, 2022		-